Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClarkson Regulatory News (CKN)

Share Price Information for Clarkson (CKN)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    0.00 (0.00%)
Bid:
4,680.00
Ask:
4,684.00
Spread: 4.00 (0.085%)
Market Cap: £1.43b
CKN Live PriceLast checked at - London Stock Exchange

Intraday Clarkson Share Chart

UPDATE RE ACQUISITION

28 Jan 2015 07:00

RNS Number : 3127D
Clarkson PLC
28 January 2015
 



This announcement and the information contained herein is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from australia, canada, Japan, the republic of south africa, the united states or any other jurisdiction in which the same would be unlawful. please see the important notice at the end of this announcement.

 

CLARKSON PLC

 

Update re acquisition

 

28 January 2015

 

Further to the announcement by Clarkson PLC ("Clarksons") on 27 November 2014 of its proposed acquisition of RS Platou ASA and the further announcement on 23 December 2014 regarding the result of the General Meeting and shareholder approval of the Acquisition, Clarksons is today pleased to announce that it has now obtained certain regulatory approvals that were conditions to Completion of the Acquisition.

 

As a result, in accordance with paragraph 5.6.19G of the Listing Rules, applications have been made to the Financial Conduct Authority for re-admission of the Existing Ordinary Shares and the admission of the Consideration Shares to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that, subject to the fulfilment of the remaining conditions, Completion of the Acquisition and Re-Admission will occur at 8.00 a.m. on 2 February 2015.

 

Under the terms of the Acquisition, the final number of Consideration Shares to be allotted and issued by Clarksons to the Sellers is 9,518,369 and following Re-Admission it is anticipated that the total number of ordinary shares that the Company has in issue will be 30,116,758.

 

Capitalised terms used in this announcement shall have the meanings as set out in the prospectus published by Clarksons on 17 December 2014.

 

For further information contact:

 

Clarkson PLC

+44 207 334 0000

Andi Case

Jeff Woyda

Nomura International plc

+44 207 102 1000

Andrew McNaught

Andrew Forrester

Nicholas Marren

Panmure Gordon (UK) Limited

Richard Gray

Andrew Potts

Tom Salvesen

+44 207 886 2500

Hudson Sandler

+44 207 796 4133

Andrew Nicolls

 

IMPORTANT NOTICE

This Announcement and the information contained in it is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia, collectively the "United States") Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction in which the same would be restricted, unlawful or unauthorised (each a "Restricted Territory"). This Announcement is for information purposes only and does not constitute an offer to sell or issue or the solicitation of an offer to buy, acquire or subscribe for shares in the capital of the Company in any Restricted Territory or to any person to whom it is unlawful to make such offer or solicitation. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions. Subject to certain exemptions, the securities referred to herein may not be offered or sold in any Restricted Territory or for the account or benefit of any national resident or citizen of any Restricted Territory.

This Announcement and the information contained herein is not an offer of securities for sale in the United States and there will be no public offer of securities in the United States. The securities discussed herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws or with any securities regulatory authority of any other state or other jurisdiction of the United States, and may not be offered, sold or transferred, directly or indirectly, in the United States absent registration under the Securities Act or an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any other state or jurisdiction of the United States.

This Announcement has been issued by, and is the sole responsibility of the Company. No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Nomura International plc ("Nomura") or Panmure Gordon (UK) Limited ("Panmure Gordon") or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Nomura, which is authorised by the Prudential Regulation Authority and is regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for the Company in relation to the Acquisition and nobody else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to the Acquisition or any other matter referred to in this Announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Nomura by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Nomura nor any of its respective affiliates accepts any responsibility whatsoever for the contents of the information contained in this Announcement or for any other statement made or purported to be made by or on behalf of Nomura or any of its respective affiliates in connection with the Company or the Acquisition. Nomura and its respective affiliates accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this Announcement and no representation or warranty, express or implied, is made by Nomura or any of its respective affiliates as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this Announcement. Nothing in this Announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future.

Panmure Gordon, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for the Company and nobody else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to any matter referred to in this Announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Panmure Gordon by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Panmure Gordon nor any of its respective affiliates accepts any responsibility whatsoever for the contents of the information contained in this Announcement or for any other statement made or purported to be made by or on behalf of Panmure Gordon or any of its respective affiliates in connection with the Company. Panmure Gordon and its respective affiliates accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this Announcement and no representation or warranty, express or implied, is made by Panmure Gordon or any of its respective affiliates as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this Announcement. Nothing in this Announcement is, or shall be relied upon as a promise or representation in this respect, whether as to the past or the future.

This Announcement does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe, for, underwrite or otherwise acquire, any securities of the Company or any member of its group in any jurisdiction or an inducement to enter into investment activity.

The information in this Announcement may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction, or disclosure of this information in whole or in part is unauthorised. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions.

The information contained in this Announcement is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained herein. You should not place undue reliance on forward-looking statements, which speak only as of the date of this Announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSEAFAWFISEDF
Date   Source Headline
29th Jun 20114:03 pmRNSDirector/PDMR Shareholding
26th May 20113:31 pmRNSDirector/PDMR Shareholding
12th May 20113:08 pmRNSResult of AGM
11th May 201112:00 pmRNSAGM and Interim Management Statement
13th Apr 201110:10 amRNSAnnual Information Update
6th Apr 20115:43 pmRNSAnnual Financial Report
5th Apr 20119:35 amRNSDirector Declaration
10th Mar 20117:00 amRNSFinal Results
4th Mar 20114:37 pmRNSHolding(s) in Company
3rd Feb 20117:00 amRNSClarkson Freight Fund & Shipping Hedge Fund
7th Jan 20111:04 pmRNSDirector/PDMR Shareholding
24th Dec 201012:44 pmRNSDirector/PDMR Shareholding
23rd Dec 20103:10 pmRNSTrading Statement
10th Dec 201012:45 pmRNSCourt Case Judgment, Contingent Liabilities
11th Nov 201012:44 pmRNSHolding(s) in Company
10th Nov 20107:00 amRNSInterim Management Statement
29th Sep 20104:16 pmRNSDirector Declaration
8th Sep 20104:24 pmRNSDoc re. Interim Report 2010
25th Aug 20107:00 amRNSInterim Results
12th Aug 20107:00 amRNSNotice of Results
30th Jun 20109:53 amRNSPre-Close Trading Update - Correction
30th Jun 20107:00 amRNSPre-Close Trading Update
13th May 201010:47 amRNSHolding(s) in Company
13th May 201010:45 amRNSResult of AGM
12th May 201010:57 amRNSAGM and Interim Management Statement
20th Apr 20103:33 pmRNSAnnual Information Update
7th Apr 20103:29 pmRNSHolding(s) in Company
31st Mar 20104:40 pmRNSAnnual Financial Report
23rd Mar 20104:37 pmRNSDirector/PDMR Shareholding
11th Mar 20107:00 amRNSFinal Results
25th Feb 201012:04 pmRNSNotice of Results
22nd Jan 201010:56 amRNSHolding(s) in Company
15th Jan 201011:30 amRNSDirector Declaration
13th Jan 20107:00 amRNSTrading Statement
17th Dec 20094:26 pmRNSDirector/PDMR Shareholding
7th Dec 20093:17 pmRNSHolding(s) in Company
30th Nov 20093:36 pmRNSDirector Declaration
20th Nov 20094:41 pmRNSDirector/PDMR Shareholding
6th Nov 20093:10 pmRNSDirector/PDMR Shareholding
6th Nov 20093:05 pmRNSDirector/PDMR Shareholding
5th Nov 20097:20 amRNSDirector/PDMR Shareholding
5th Nov 20097:00 amRNSInterim Management Statement
4th Nov 20095:11 pmRNSHolding(s) in Company
30th Oct 200910:10 amRNSDirector/PDMR Shareholding
30th Sep 20093:49 pmRNSTotal Voting Rights
11th Sep 20093:48 pmRNSDirector/PDMR Shareholding
11th Sep 200911:50 amRNSDoc re. Interim Report 2009
7th Sep 20092:41 pmRNSAdditional Listing
2nd Sep 20093:57 pmRNSAdditional Listing
27th Aug 20097:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.